Clinical Trial Update: Dose Defining Study for the Administration of Vitamin K2 Supplements in Hemodialysis Patients [Phase 3]

View source ↗

Summary

A Phase 3 dose-defining study assessing the administration of Vitamin K2 supplements in patients undergoing hemodialysis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Vascular Calcification

Drugs mentioned

• Vitamin K2 supplement (menaquinone)

Snippet

Sponsor: Rogier Caluwe | Conditions: Vascular Calcification | Phase 3 | Status: COMPLETED